These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 2401949)
1. [Application of the Weibull function to the study of in vivo/in vitro correlation]. Rodriguez F; Arama E; Magbi M; Paulin T; Rouffiac R J Pharm Belg; 1990; 45(3):173-83. PubMed ID: 2401949 [TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-vivo correlation for two gliclazide extended-release tablets. Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192 [TBL] [Abstract][Full Text] [Related]
4. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632 [TBL] [Abstract][Full Text] [Related]
5. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Souliman S; Blanquet S; Beyssac E; Cardot JM Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713 [TBL] [Abstract][Full Text] [Related]
6. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035 [TBL] [Abstract][Full Text] [Related]
7. In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times. Brockmeier D Arzneimittelforschung; 1984; 34(11):1604-7. PubMed ID: 6543138 [TBL] [Abstract][Full Text] [Related]
8. Theophylline controlled-release formulations: in vivo-in vitro correlations. Yu Z; Schwartz JB; Sugita ET Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400 [TBL] [Abstract][Full Text] [Related]
9. In vitro-in vivo relationships for oral extended-release drug products. Mauger DT; Chinchilli VM J Biopharm Stat; 1997 Nov; 7(4):565-78. PubMed ID: 9358329 [TBL] [Abstract][Full Text] [Related]
10. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption. Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of in vitro/in vivo correlation for three kinds of self-designed sustained-release nitrendipine formulations using deconvolution method]. Yang MS; You BG; Yang MH; Cun DM; Tao AJ; Cui FD Yao Xue Xue Bao; 2004 Sep; 39(9):738-41. PubMed ID: 15606026 [TBL] [Abstract][Full Text] [Related]
12. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur. Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057 [TBL] [Abstract][Full Text] [Related]
13. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride. Bendas ER Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589 [TBL] [Abstract][Full Text] [Related]
14. [The pharmacokinetics and bioavailability of urapidil. In vitro/in vivo correlations of different experimental formulations]. Gielsdorf W; Nieder M; Molz KH; Jaeger H; Haerlin R; Radtke HW Arzneimittelforschung; 1986 Aug; 36(8):1265-7. PubMed ID: 3778565 [TBL] [Abstract][Full Text] [Related]
15. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009 [TBL] [Abstract][Full Text] [Related]
16. [Release of norfenefrine from sustained-release formulations by an in vitro dissolution model. Simulation of "drug levels" by calculation using pharmacokinetical constants and comparison with in vivo course of action (author's transl)]. Laven R; Schäfer EA Arzneimittelforschung; 1981; 31(2):353-6. PubMed ID: 7194653 [TBL] [Abstract][Full Text] [Related]
17. A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption. Dunne A; O'Hara T; Devane J Stat Med; 1999 Jul; 18(14):1865-76; discussion 1877. PubMed ID: 10407257 [TBL] [Abstract][Full Text] [Related]
18. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. Brockmeier D; von Hattingberg HM Arzneimittelforschung; 1982; 32(3):248-51. PubMed ID: 6896279 [TBL] [Abstract][Full Text] [Related]
19. Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: a plasma and a saliva study. Gandia P; Bareille MP; Saivin S; Le-Traon AP; Lavit M; Guell A; Houin G J Clin Pharmacol; 2003 Nov; 43(11):1235-43. PubMed ID: 14551178 [TBL] [Abstract][Full Text] [Related]
20. In vitro - in vivo correlation: from theory to applications. Emami J J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]